Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia
Pyeonghwa Jeong, Yeongyu Moon, Je‐Heon Lee, So‐Deok Lee, Jiyeon Park, Jung-Eun Lee, Jiheon Kim, Hyo‐Jeong Lee, Na Yoon Kim, Jungil Choi, Jeong‐Doo Heo, Ji Eun Shin, Hyun Woo Park, Yoon-Gyoon Kim, Yoon-Gyoon Kim, Sun‐Young Han, Yong‐Chul Kim, Yong‐Chul Kim
Topics & Concepts
IndirubinChemistryMyeloid leukemiaPharmacologyFms-Like Tyrosine Kinase 3LeukemiaIn vivoHaematopoiesisEx vivoCancer researchIn vitroBiochemistryStem cellImmunologyMedicineBiologyVisual artsGeneGeneticsArtMutationBiotechnologyIndigoChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia ResearchQuinazolinone synthesis and applications